Saudi Arabia is considered the largest pharmaceutical market in the Middle East, North Africa, and the Gulf region.

This growth is expected to continue through 2023. Despite having more than 50 registered pharmaceutical manufacturing units, the local industry still does not fully meet demand. This gap presents a unique opportunity for international pharmaceutical companies to contribute to the Kingdom’s healthcare sector.